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Aims Coronary computed tomography angiography (CTA) has emerged as a non-invasive diagnostic method for patients
with suspected coronary artery disease, but its usefulness in patients with complex coronary artery disease remains
to be investigated. The present study sought to determine the agreement between separate heart teams on treat-
ment decision-making based on either coronary CTA or conventional angiography.
...................................................................................................................................................................................................
Methods
and results
Separate heart teams composed of an interventional cardiologist, a cardiac surgeon, and a radiologist were randomized
to assess the coronary artery disease with either coronary CTA or conventional angiography in patients with de novo
left main or three-vessel coronary artery disease. Each heart team, blinded for the other imaging modality, quantified
the anatomical complexity using the SYNTAX score and integrated clinical information using the SYNTAX Score II to
provide a treatment recommendations based on mortality prediction at 4 years: coronary artery bypass grafting
(CABG), percutaneous coronary intervention (PCI), or equipoise between CABG and PCI. The primary endpoint was
the agreement between heart teams on the revascularization strategy. The secondary endpoint was the impact of
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fractional flow reserve derived from coronary CTA (FFRCT) on treatment decision and procedural planning.
Overall, 223 patients were included. A treatment recommendation of CABG was made in 28% of the cases with cor-
onary CTA and in 26% with conventional angiography. The agreement concerning treatment decision between coron-
ary CTA and conventional angiography was high (Cohen’s kappa 0.82, 95% confidence interval 0.74–0.91). The heart
teams agreed on the coronary segments to be revascularized in 80% of the cases. FFRCT was available for 869/1108
lesions (196/223 patients). Fractional flow reserve derived from coronary CTA changed the treatment decision in 7%
of the patients.
...................................................................................................................................................................................................
Conclusion In patients with left main or three-vessel coronary artery disease, a heart team treatment decision-making based
on coronary CTA showed high agreement with the decision derived from conventional coronary angiography sug-
gesting the potential feasibility of a treatment decision-making and planning based solely on this non-invasive imag-
ing modality and clinical information.
...................................................................................................................................................................................................
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Introduction
Myocardial revascularization improves survival in patients with multi-
vessel coronary artery disease.1 The selection of a surgical or
catheter-based therapy relies on patient’s preference, clinical comor-
bidities, and complexity of coronary artery disease. The American
and European guidelines support a heart team approach for the
decision-making process regarding the revascularization strategy and
recommend the evaluation of the anatomical complexity using the
SYNTAX score.2,3
Invasive coronary angiography has been the preferred diagnostic
modality to assess the extent and severity of the coronary artery dis-
ease. Coronary computed tomography angiography (CTA) has
emerged as a non-invasive method able to assess the degree of
epicardial coronary narrowing, and its physiological repercussion
by means of fractional flow reserve derived from computed tom-
ography (FFRCT).
4–6 Moreover, the calculation of the SYNTAX
score derived from coronary CTA has been shown to be accurate
with respect to the one derived from invasive angiographic asses-
sment.7 The integration of the anatomical SYNTAX score with
patient’s clinical characteristics and comorbidities using the
SYNTAX Score II, provides a treatment recommendation based
on the predicted 4-year mortality in patients undergoing coronary
artery bypass grafting surgery (CABG) or percutaneous coronary
intervention (PCI).8,9
Technological advancements in the field of coronary computed
tomography (CT) allowed for expanding its use to patients with
known coronary artery disease. However, the diagnostic perform-
ance of the latest generation of CT scanners and the agreement on
treatment decision in patients with multivessel coronary artery dis-
ease remains to be investigated. The present study sought to deter-
mine the agreement between separate heart teams on treatment
recommendation based either on coronary CTA or conventional
angiography in patients with left main or three-vessel coronary artery
disease.
Methods
Study design
The design of the SYNTAX III REVOLUTION Trial: A Randomized Study
Investigating the Use of CT Scan and Angiography of the Heart to Help the
Doctors Decide Which Method is the Best to Improve Blood Supply to the Heart
in Patients With Complex Coronary Artery Disease has been reported pre-
viously.10 The trial was an international, multicentre study, randomizing
separate heart teams to make a treatment decision between CABG and
PCI, using either coronary CTA or conventional angiography, while
blinded to the other imaging modality. Details of the organization of the
study and protocol are provided in the Supplementary material online,
Appendix. The trial was approved by the investigational review board or
ethics committee at each participating centre. The study was sponsored
by the European Cardiovascular Research Institute (ECRI, Rotterdam, the
Netherlands) with unrestricted grants from GE Healthcare (Chicago, IL,
USA) and Heart Flow Inc. (Redwood City, CA, USA). The principal investi-
gators (the first two authors and the corresponding authors) had unre-
stricted access to the data, were involved in the analysis and interpretation
of the data. The principal investigators guarantee the completeness and ac-
curacy of the data and analyses and the fidelity of the trial to the protocol.
Enrolment and randomization
Patients with left main or three-vessel coronary artery disease, diagnosed
with either coronary CTA or conventional angiography and candidates
for either CABG or PCI were assessed for eligibility. Patients were con-
sented to participate in a randomized trial of decision making between
CABG and PCI performed by the local heart team. In addition to the diag-
nostic method used for assessment of eligibility, patients underwent
evaluation with the alternative imaging modality. Separate heart teams
constituted by an interventional cardiologist, a cardiac surgeon, and a
radiologist specialized in cardiac imaging were randomized to either as-
sess the coronary anatomy with coronary CTA or conventional angiog-
raphy in addition to the patient’s clinical information. Randomization was
performed by a web-based system. Each heart team calculated the ana-
tomical SYNTAX score based solely on their allocated imaging modality
and subsequently integrated the clinical information to compute the
3690 C. Collet et al.
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..SYNTAX Score II risk prediction model providing a treatment recom-
mendation, i.e. CABG, PCI, or equipoise between CABG and PCI. The
SYNTAX Score II is a validated tool predicting patient-specific 4-year
mortality based on age, gender, kidney function, left ventricular ejection
fraction, presence of chronic obstructive pulmonary disease, and periph-
eral vascular disease.9,11 Angiographic characteristics such as the pres-
ence of left main stem disease and the anatomical SYNTAX score are
also accounted for in the calculation.11 Finally, the heart team selected
the revascularization strategy and planned the procedure (i.e. CABG or
PCI). Any anatomical SYNTAX score was eligible for screening and
patients with anatomical SYNTAX score >33 were not excluded.12
Patients with prior revascularization were excluded. Complete details of
the inclusion and exclusion criteria are provided in the Supplementary
material online, Table S1.
Image acquisition and analysis
Coronary CTA was performed with the GE Revolution CT scanner that
has a nominal spatial resolution of 230 microns along the X–Y planes, a
rotational speed of 0.28 s, and a Z-plane coverage of 16 cm enabling to
image the heart in one heartbeat.13 A proprietary post-processing algo-
rithm allowed for the correction of motion artefacts.13 The imaging ac-
quisition guidelines are detailed in the Supplementary material online,
Table S2. The protocol mandated the use of nitrates prior to CT acquisi-
tion and beta-blockers in cases of heart rate higher than 65 b.p.m. Image
quality was assessed using the five-point Likert scale at the patient level.14
Severity and extension of coronary artery disease were assessed using
the anatomical SYNTAX score, coronary segments with narrowing with
visual diameter stenosis >50% using coronary CTA, or conventional angi-
ography and weighted according to their location in the coronary tree
were included in the calculation.15–18 For the primary endpoint, the two
local heart teams made their decision on the choice of revascularization
mode based on their clinical and anatomical assessment.
For the secondary endpoint, the FFRCT was used to calculate the non-
invasive functional SYNTAX score, which was computed by the core
laboratory (Cardialysis BV, Rotterdam, the Netherlands) subtracting
non-flow limiting stenosis (FFRCT >0.80) from the coronary CTA-
Figure 1 A flow chart of the study. FFRCT, fractional flow reserve derived from coronary computed tomography angiography.
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derived anatomical SYNTAX score.17 Finally, the non-invasive functional
SYNTAX score was used to calculate the SYNTAX Score III, which is
conceptually a combination of coronary anatomical complexity with its
physiological repercussion and patient’s clinical characteristics and
comorbidities.
Objectives and endpoints
The trial was designed to determine the agreement between separate
heart teams on treatment recommendation and planning based either on
coronary CTA (with and without FFRCT) or conventional angiography.
The primary endpoint based on anatomical assessment was the agree-
ment, assessed by Cohen’s kappa, on the revascularization strategy be-
tween separate heart teams.
For the secondary endpoints, the heart team allocated to coronary
CTA received the FFRCT and made a second treatment recommendation
integrating the functional assessment. Finally, both heart teams were
unblinded to all imaging modalities and made a final clinical decision on
the revascularization strategy. Definitions of the endpoints are provided
in Supplementary material online, Table S3 in the Appendix.
Statistical analysis
For both diagnostic imaging strategies, the heart team’s treatment recom-
mendation led to one of three decisions according to the SYNTAX
Score II: (i) CABG, patients should be treated by CABG due to a higher
4-year mortality with PCI, (ii) PCI, patients should be treated by PCI due
to a higher 4-year mortality with CABG, and (iii) equipoise between
CABG and PCI, patients could be treated by either approach, considering
that the 4-year mortality prediction is similar between the two revascula-
rization modalities.
The primary endpoint was the agreement upon two treatment recom-
mendations of CABG or PCI/equipoise. The SYNTAX III REVOLUTION
Trial was powered to show a substantial agreement (Cohen’s kappa
0.60–0.80) between the separate heart team’s treatment recommenda-
tions based on the allocated imaging modality.10,19 Given the assumption
that both coronary CTA and conventional angiography diagnostic algo-
rithms will result in a CABG treatment recommendation in 30% of
patients, we estimated that a random heart team assignment of 223
patients would provide a 90% power to show at least substantial agree-
ment (at a two-sided alpha level of 0.05), assuming an attrition rate of
10%.17,19 The agreement on the SYNTAX score between the two imag-
ing modalities was assessed by the Bland–Altman and Passing Bablok
method.20,21 Categorical variables were compared with the use of the
McNemar. Continuous variables were compared with the use of
Student’s t-test or the Wilcoxon rank-sum test for non-normally distrib-
uted data. A two-sided P-value of 0.05 or less was considered to indicate
statistical significance. All statistical analyses were performed with the use
of SAS software, version 9.4 (SAS Institute).
Results
From 29 June 2016 to 8 February 2018, 223 patients with left main or
three-vessel coronary artery disease were enrolled in six centres
from five European countries. Figure 1 shows the study flow chart
and Supplementary material online, Table S4 in the Appendix shows
the method used for screening.
Baseline clinical and angiographic
characteristics
Baseline clinical characteristics are shown in Table 1. The five-point
Likert score was 3.15± 0.95. The radiation dose (effective dose) was
significantly lower with CTA compared with conventional
angiography (5.0± 3.0 mSv vs. 10.1 ± 16 mSv, P< 0.0001). Using cor-
onary CTA, 1108 stenoses (5.0± 1.7 per patient) were detected. The
mean anatomical SYNTAX score derived from coronary CTA was
33.9 ± 13.0. Conventional coronary angiography identified 1073 sten-
oses (4.8± 1.7 per patient) with a mean SYNTAX score of
30.3 ± 12.2. Details of the SYNTAX score, its components and differ-
ences between the diagnostic imaging modalities are shown in
Table 2 and Take home figure shows a case example. The mean differ-
ence between coronary CTA and conventional angiography-derived
SYNTAX score was 3.58 (limits of agreement -18.8 to 25.9) with a
correlation coefficient of 0.59 (P< 0.0001) without systematic or
proportional differences (Figure 2A). The agreement on diseased
segments between imaging modalities was observed in 85% of the
cases.
.................................................................................................
Table 1 Baseline clinical characteristics
Characteristics N5 223 patients
Demographics
Age (years), mean ± SD 67.6 ± 8.9
Male (%, n) 84.3 (188/223)
Coronary artery disease risk factors
Current smoking (%, n) 22.6 (48/212)
Diabetes mellitus (%, n) 37.7 (84/223)
Treatment for diabetes (%, n)
Insulin 10.3 (23/223)
Medication 25.6 (57/223)
Diet 0.9 (2/223)
Hypertension (%, n) 74.9 (167/223)
Hyperlipidaemia (%, n) 70.0 (154/220)
Family history of CAD (%, n) 35.6 (67/188)
Medical history
Previous stroke (%, n) 8.1 (18/223)
Previous myocardial infarction (%, n) 0.9 (2/220)
COPD (%, n) 13.0 (29/223)
PVD (%, n) 17.5 (39/223)
Clinical presentation
Silent ischaemia (%, n) 42.2 (94/223)
Stable angina (%, n) 48.9 (109/223)
CCS class (%, n)
I 15.6 (17/109)
II 56.0 (61/109)
III 25.7 (28/109)
IV 2.8 (3/109)
Unstable angina (%, n) 9.0 (20/223)
BMI (kg/m2), mean ± SD 26.5 ± 3.7
Creatinine clearance (mL/min) mean ± SD 81.6 ± 27.5
LVEF (%), mean ± SD 54.6 ± 11.0
Heart rate during CT acquisition, mean ± SD 54.6 ± 11.0
BMI, body mass index; CAD, coronary artery disease; CCS, Canadian
Cardiovascular Society; COPD, chronic obstructive pulmonary disease; LVEF, left
ventricle ejection fraction; SD, standard deviation.
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Primary endpoint
The SYNTAX Score II provided a treatment recommendation of
CABG in 28% of patients with the coronary CTA and in 26% with
conventional angiography (Table 3). Patient’s characteristics according to
the SYNTAX Score II treatment recommendation are shown in
Table 4. The agreement on the anatomical SYNTAX score tertiles was
fair [Kappa 0.33, 95% confidence interval (CI) 0.23–0.42; Supplementary
material online, Table S5 in the Appendix]. The agreement concerning
revascularization treatment recommendation between imaging modal-
ities was almost perfect, according to the statistical nomenclature of
Cohens’ kappa, with a coefficient of 0.82 (95% CI 0.73–0.90; Table 2).
The mean difference between coronary CTA and conventional
angiography-derived SYNTAX Score II was -0.01 (limits of agreement
-5.1 to 4.9) with a correlation coefficient of 0.98 (P < 0.001) without
systematic or proportional differences (Figure 2B),
Procedural planning
Coronary artery bypass grafting was selected as the revasculariza-
tion strategy in 164 patients using coronary CTA (58 patients with
CABG recommendation and 106 with equipoise CABG or PCI
recommendation according to the SYNTAX Score II) and in 155
patients with conventional angiography (62 patients with CABG
recommendation and 106 with equipoise CABG or PCI recom-
mendation according to the SYNTAX Score II). Overall, the heart
teams agreed on the coronary segments to be revascularized in
81.1% of the cases.
Impact of physiological assessment
Fractional flow reserve derived from CTA was available for 868/1108
lesions. The mean FFRCT value was 0.64 ± 13. Non-flow limiting sten-
osis (FFRCT >0.80) were observed in 34% (66/196) of the patients
(n= 116 lesions). Fractional flow reserve derived from coronary
CTA changed the treatment decision in 7% (14/196) of the patients,
in 13 patients the surgical procedure was changed to a percutaneous
approach. The non-invasive functional assessment score led to a re-
duction in the anatomical SYNTAX of 2.9 points (95% CI 1.9–3.9)
and reduced the proportion of patients with haemodynamically sig-
nificant three-vessel disease from 92.3% to 78.8%. Furthermore, the
....................................................................................................................................................................................................................
Table 2 Comparison of the anatomical SYNTAX score and SYNTAX score II and its components
Characteristics Heart team
assessment based on
conventional angiography
Heart team
assessment based on
coronary CTA
P-value
Anatomical SYNTAX score, per patient 30.3 ± 12.2 33.9 ± 13.0 <0.001
Diseased vessels
Left main 28.7% (64/223) 36.0% (80/222) 0.10
RCA 92.4% (206/223) 95.5% (212/222) 0.54
LAD 96.4% (215/223) 99.5% (221/222) 0.021
LCX 95.1% (212/223) 95.0% (211/222) 0.96
Components anatomical SYNTAX score
Total occlusion 14.0% (150/1073) 12.0% (133/1108) 0.17
Bifurcation 22.0% (236/1073) 23.4% (259/1108) 0.44
Medina 1,0,0 1.7% (18/1073) 1.1% (12/1108) —
Medina 0,1,0 2.6% (28/1073) 0.8% (9/1108) —
Medina 1,1,0 4.4% (47/1073) 6.9% (77/1108) —
Medina 1,1,1 6.8% (73/1073) 8.6% (95/1108) —
Medina 0,0,1 2.4% (26/1073) 1.8% (20/1108) —
Medina 1,0,1 2.2% (24/1073) 1.9% (21/1108) —
Medina 0,1,1 1.9% (20/1073) 2.3% (25/1108) —
Aorto ostial lesion 3.3% (35/1073) 3.6% (40/1108) 0.70
Severe tortuositya 2.2% (24/1073) 0.9% (10/1108) 0.014
Length >20 mm 29.1% (269/923) 30.4% (296/975) 0.51
Heavy calcificationb 13.0% (140/1073) 28.9% (320/1108) <0.001
Thrombus 0.3% (3/1073) 0.3% (3/1108) 1.0
SYNTAX score II for PCI 35.9 ± 10.8 36.8 ± 10.9 0.38
PCI 4-year mortality (%) 14.9 ± 14.7 16.0 ± 15.8 <0.001
SYNTAX score II for CABG 32.0 ± 11.7 32.2 ± 11.6 0.86
CABG 4-year mortality (%) 11.8 ± 12.8 12.0 ± 12.8 0.87
CABG, coronary bypass graft; LAD, left anterior descending; LCX, left circumflex; PCI, percutaneous coronary intervention; RCA, right coronary artery.
aOne or more bends of 90 or more, or three or more bends of 45 to 90 proximal of the diseased segment.
bFor computed tomography angiography defined as presence of calcium that encompasses more than 50% of the cross-sectional area of the vessel at any location within the
specific lesion. For invasive angiography defined as multiple persisting opacifications of the coronary wall visible in more than one projection surrounding the complete lumen of
the coronary artery at the site of the lesion.
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Take home ﬁgure Case example of the non-invasive and invasive assessment using the anatomical SYNTAX score and SYNTAX Score II. A
74-year-old man with a creatinine clearance 38 mL/min and left ventricular ejection fraction of 50% without history of chronic obstructive pulmonary
disease or peripheral vascular disease. At the top, coronary computed tomography angiography shows three-vessel disease with a coronary narrow-
ings located at the ostium and in the proximal segment of the right coronary artery; two narrowings located in the mid segment of the left anterior
descending artery; and one additional narrowing in the proximal segment of the left circumflex artery involving the bifurcation with the first obtuse
marginal coronary artery. Conventional angiography revealed also a three-vessel disease with one narrowing located at the proximal segment of the
right coronary artery, one narrowing at the mid segment of the left anterior descending artery, and a bifurcation lesion involving the proximal seg-
ment of the left circumflex artery and the first obtuse marginal coronary artery. Each coronary narrowing was scored according to the anatomical
SYNTAX score and the final anatomical SYNTAX score derived from each modality is shown. With both imaging modalities, the SYNTAX score II
recommended either coronary artery bypass graft surgery or percutaneous coronary intervention based on a comparable predicted 4-year mortality.
At the bottom, the non-invasive fractional flow reserve derived from coronary computed tomography angiography (FFRCT) is presented. The FFRCT
showed that the lesions in the right coronary artery are not haemodynamically relevant, whereas the left anterior descending artery and left circum-
flex artery have haemodynamically relevant lesions. The treatment recommendation based on coronary computed tomography angiography with
FFRCT remained equipoise between coronary artery bypass graft surgery and percutaneous coronary intervention but the treatment planning
changed based on the negative FFRCT results in the right coronary artery. CABG, coronary artery bypass graft surgery; LAD, left anterior descending
artery; LCX, left circumflex artery; PCI, percutaneous coronary intervention; RCA, right coronary artery.
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use of the non-invasive functional SYNTAX score for the SYNTAX
Score II calculation (SYNTAX Score III) corrected for the overesti-
mation of the predicted mortality for PCI at 4 years (Table 2).
Unblinding and outcomes
The unblinding of conventional angiography in the CT arm changed
the treatment recommendation in 9% of the cases, whereas the
unblinding of CTA with FFRCT modified the treatment recommenda-
tion in 6.3% of the patients in the conventional angiography arm. The
heart team’s treatment decision was concordant in 91% of the cases
after unblinding to all imaging modalities.
The decisions based on coronary CTA and conventional angiog-
raphy were in agreement with the treatment executed in 71% and
78% of the patients, respectively.
Discussion
By randomizing two heart teams, the present study showed that
treatment decision-making based on coronary CTA is in an almost
perfect agreement with the treatment decision derived from conven-
tional coronary angiography in patients with left main or three-vessel
coronary artery disease. The anatomical SYNTAX scores derived
Figure 2 Correlation and agreement on the anatomical SYNTAX score (A) and SYNTAX score II (B) between coronary computed tomography
angiography and conventional angiography.
The SYNTAX III REVOLUTION trial 3695
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..either from coronary CTA or conventional angiography showed a
moderate degree of correlation, whereas the SYNTAX Score II dem-
onstrated a high degree of correlation between the two diagnostic
strategies. Furthermore, the agreement on the revascularization
strategy between coronary CTA and conventional angiography
reached 80%.
For patients with multivessel disease, a multidisciplinary heart team
approach is currently advocated by the guidelines for treatment
decision-making with a Class I recommendation level of evidence ‘C’
in the absence of evidence from randomized trial.2 The SYNTAX III
REVOLUTION is the first study to randomize the heart team; the al-
most perfect agreement upon treatment selection supports the
usefulness of coronary CTA in patients with complex coronary ar-
tery disease. It should be also recognized that in the current study the
heart team routinely included a radiologist in addition to an interven-
tional cardiologist and a cardiac surgeon, which differs from the defin-
ition of heart team in the guidelines. The interaction with the
radiologist enhanced image interpretation and decision-making
process.
In line with previous findings, the anatomical SYNTAX score was
higher with coronary CTA compared to conventional angiography;
this difference may be related to the higher sensitivity of CT in
detecting calcified plaques that due to the blooming artefact may
hamper luminal assessment increasing the anatomical SYNTAX
..........................................................................................................
....................................................................................................................................................................................................................
Table 3 Agreement on treatment recommendation between coronary computed tomography and conventional
angiography
Heart team treatment recommendation based
on coronary computed tomography angiography
Heart team treatment recommendation
based on conventional angiography
CABG PCI/equipoise CABG and PCI
CABG 23.4% (52/222) 2.7% (6/222)
PCI/Equipoise CABG and PCI 4.5% (10/222) 69.4% (154/222)
Cohen’s kappa 0.82 (95% CI 0.73–0.910)
Agreement in 93% of the heart team’s treatment recommendation.
CABG, coronary bypass graft; PCI, percutaneous coronary intervention.
....................................................................................................................................................................................................................
Table 4 Patients characteristics according to the SYNTAX score II treatment recommendation
Characteristics Treatment Recommendation PCI only
or Equipoise PCI and CABGa (n5 165)
Treatment Recommendation
CABG onlya (n558)
P-value
Age (years), mean ± SD 68.5 ± 8.5 65.0 ± 9.5 0.009
Male (%, n) 95.8% (158/165) 51.7% (30/58) <0.001
Current smoking (%, n) 21.0% (33/157) 27.3% (15/55) 0.02
Diabetes mellitus (%, n) 34.5% (57/164) 48.3% (28/58) 0.004
Hypertension (%, n) 73.9% (122/165) 77.6% (45/58) 0.581
Hyperlipidaemia (%, n) 67.1% (110/164) 78.6% (44/56) 0.105
Family history of CAD (%, n) 31.7% (44/139) 46.9% (23/49) 0.055
Previous stroke (%, n) 8.5% (14/165) 6.9% (4/58) 1.0
Previous myocardial infarction (%, n) 1.2% (2/163) 0.0% (0/57) 1.0
COPD (%, n) 17.6% (29/165) 0.0% (0/58) <0.001
PVD (%, n) 18.8% (31/165) 13.8% (8/58) 0.389
Creatinine clearance (mL/min), mean ± SD 81.6 ± 24.5 81.8 ± 34.8 0.960
LVEF (%), mean ± SD 56.7 ± 9.0 48.9 ± 13.8 <0.001
Left main disease (%, n) 33.9% (56/165) 13.8% (8/58) 0.003
Anatomical SYNTAX score, per patient 29.1 ± 12.0 33.8 ± 12.2 0.011
SYNTAX score II PCI, mean ± SD 34.2 ± 9.8 40.8 ± 12.0 <0.001
PCI predicted 4-year mortality (%) 12.6 ± 11.0 21.4 ± 20.9 0.003
SYNTAX score II CABG, mean ± SD 34.1 ± 11.5 26.3 ± 10.3 <0.001
CABG predicted 4-year mortality (%) 13.4 ± 13.6 7.2 ± 8.6 <0.001
CABG, coronary artery bypass grafting; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; PCI, percutaneous
coronary intervention; PVD, peripheral vascular disease.
aBased on the SYNTAX score II recommendation using the anatomic SYNTAX score derived from conventional angiography.
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score.17,22 In the present study, heavily calcified lesions were identi-
fied in 57.7% of patients with coronary computed tomography angi-
ography and in 34.5% using conventional angiography (P< 0.001).
Despite the difference observed in the anatomical SYNTAX score,
the addition of clinical information mitigated that difference and
improved the correlation on the 4-years mortality prediction be-
tween imaging strategies (Take home figure), resulting in a similar
treatment recommendation in 93% of the cases.8
In patients with multivessel coronary artery disease, physiology-
guided revascularization reduces the rate of major adverse cardiovas-
cular events compared with an angiography guided PCI.23 In the
SYNTAX II study, invasive physiological evaluation led to a reduction
of 56% in the proportion of patients with haemodynamically signifi-
cant three-vessel disease. Moreover, comparable proportion of
patients were reclassified to a lower risk category using the functional
SYNTAX score derived either from invasive pressure-wire or FFRCT
assessment.17,24 The extension and severity of coronary artery dis-
ease was overestimated by coronary CTA compared with conven-
tional angiography; this influenced the SYNTAX Score II predictions
resulting in higher predicted mortality risk with the SYNTAX Score
II. However, FFRCT corrected the overestimation of the anatomical
SYNTAX score and adjusted the SYNTAX Score II, ensuing similar
predicted outcome with respect to conventional angiography.
In the present study, the mean FFR value is the lowest reported in
the literature (0.63± 13) reflecting the severity of coronary artery
disease of the patients included in the trial. Use of FFRCT reduced the
percentage of patients with significant three-vessel disease from
92.2% to 78.8%, changing treatment recommendation in 7% of
patients. Furthermore, by combining anatomical complexity of the
coronary artery disease with its physiological repercussion and clinic-
al information the SYNTAX Score III enabled the heart team to refine
the decision-making process regarding the optimal revascularization
strategy and treatment planning of haemodynamically significant
lesions in a non-invasive setting. The unblinding to both imaging
modalities changed the heart team’s treatment recommendation in
less than 10% of the cases supporting the almost perfect agreement
observed in the primary endpoint. Also, the design of the present trial
allows us to determine the heart team’s treatment recommendation
variability based on multimodality imaging. In 91% of the cases, treat-
ment recommendations were concordant between heart teams.
Previous attempts of using non-invasive coronary CT imaging in
patients with three-vessel disease have shown moderate feasibility.17
In this trial, a new CT scanner was selected that could acquire the
heart in one beat with high temporal resolution and high-definition
spatial resolution. Such technology rendered feasible the conduction
of the present study and enabled a high analysability rate along with a
robust feasibility for FFRCT processing in this complex population.
Moreover, the effective dose was lower with CT compared with con-
ventional angiography, confirming the safety of new scanners in term
of radiation dose. These findings support the expansion of coronary
CTA to patients with complex coronary artery disease.
The present study must be cautiously interpreted with respect to
some limitations. First, in the SYNTAX III REVOLUTION population
several subgroups were under-represented such as women, patients
with low ejection fraction, and patients with unstable clinical presen-
tation. Second, the unblinding to the alternative imaging modality
prior to the final clinical decision precluded the investigation of the
safety and feasibility of this strategy solely based on non-invasive
imaging. Furthermore, in absence of outcome data a strategy solely
based on non-invasive imaging to select patients for surgery cannot
be recommended; an outcome trial with treatment selection based
on coronary CT is warranted and is currently in design. Third, inher-
ent to the decision-making trial design, treatment selection bias can-
not be excluded, but it was reassuring to observe a comparable
proportion of agreement between the executed treatment and the
coronary CTA or conventional angiography arms. Nevertheless, it
should be acknowledged that in 28% with coronary CTA and 21%
with conventional angiography the treatment recommendation dif-
fered from the treatment executed. Finally, only one type of CT scan-
ner was used in SYNTAX III REVOLUTION, if these results can be
extrapolated to other technologies requires further investigation.
Conclusion
In patients with left main or three-vessel coronary artery disease, a
heart team treatment decision-making based coronary CTA showed
a high agreement with the decision derived from conventional coron-
ary angiography suggesting the potential feasibility of a treatment
decision-making based solely on this non-invasive imaging modality
and clinical information.
Supplementary material
Supplementary material is available at European Heart Journal online.
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